Literature DB >> 20393114

Tear osmolarity as a biomarker for dry eye disease severity.

Mari Suzuki1, Morgan L Massingale, Fen Ye, James Godbold, Tali Elfassy, Maithreyi Vallabhajosyula, Penny A Asbell.   

Abstract

PURPOSE: To study the association between tear osmolarity and dry eye severity grade, based on a modified Dry Eye Workshop (DEWS) scale, and between osmolarity and the signs and symptoms that determine dry eye disease severity.
METHODS: Nineteen patients with dry eye disease were asked to complete an evaluation of dry eye signs and symptoms composed of the Ocular Surface Disease Index (OSDI) questionnaire, corneal staining with fluorescein, conjunctival staining with lissamine green, tear-film breakup time (TFBUT), Schirmer's test with anesthesia, and tear sample collection. Tear samples were collected in 5-microL microcapillaries. Tear osmolarity was measured in the right eye with a tear osmometer.
RESULTS: Tear osmolarity correlated significantly with dry eye severity grade (modified DEWS). Schirmer's test and tear osmolarity correlated significantly at r=-0.52, with Schirmer's test result, with adjustment for age, contributing significantly to the independent estimate of tear osmolarity.
CONCLUSIONS: Tear osmolarity correlates with dry eye severity and therefore could provide a biomarker for disease severity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20393114     DOI: 10.1167/iovs.09-4596

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  28 in total

1.  Comparison of the effects of first and second generation silicone hydrogel contact lens wear on tear film osmolarity.

Authors:  Guzin Iskeleli; Yunus Karakoc; Ahmet Ozkok; Ceyhun Arici; Omer Ozcan; Osman Ipcioglu
Journal:  Int J Ophthalmol       Date:  2013-10-18       Impact factor: 1.779

2.  Tear cytokine profile as a noninvasive biomarker of inflammation for ocular surface diseases: standard operating procedures.

Authors:  Yi Wei; Neha Gadaria-Rathod; Seth Epstein; Penny Asbell
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-23       Impact factor: 4.799

Review 3.  TFOS DEWS II Tear Film Report.

Authors:  Mark D P Willcox; Pablo Argüeso; Georgi A Georgiev; Juha M Holopainen; Gordon W Laurie; Tom J Millar; Eric B Papas; Jannick P Rolland; Tannin A Schmidt; Ulrike Stahl; Tatiana Suarez; Lakshman N Subbaraman; Omür Ö Uçakhan; Lyndon Jones
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

4.  New testing options for diagnosing and grading dry eye disease.

Authors:  Gary N Foulks; Stephen C Pflugfelder
Journal:  Am J Ophthalmol       Date:  2014-03-12       Impact factor: 5.258

5.  Dry eye disease: A review of diagnostic approaches and treatments.

Authors:  Hui Lin; Samuel C Yiu
Journal:  Saudi J Ophthalmol       Date:  2014-06-24

6.  Discordant Dry Eye Disease (An American Ophthalmological Society Thesis).

Authors:  Roni M Shtein; Daniel E Harper; Vincent Pallazola; Steven E Harte; Munira Hussain; Alan Sugar; David A Williams; Daniel J Clauw
Journal:  Trans Am Ophthalmol Soc       Date:  2016-08

Review 7.  Topical treatments for blepharokeratoconjunctivitis in children.

Authors:  Michael O'Gallagher; Catey Bunce; Melanie Hingorani; Frank Larkin; Stephen Tuft; Annegret Dahlmann-Noor
Journal:  Cochrane Database Syst Rev       Date:  2017-02-07

8.  EMMPRIN modulates epithelial barrier function through a MMP-mediated occludin cleavage: implications in dry eye disease.

Authors:  Eric Huet; Benoit Vallée; Jean Delbé; Samia Mourah; Virginie Prulière-Escabasse; Magali Tremouilleres; Kenji Kadomatsu; Serge Doan; Christophe Baudouin; Suzanne Menashi; Eric E Gabison
Journal:  Am J Pathol       Date:  2011-07-21       Impact factor: 4.307

9.  Post-LASIK dry eye.

Authors:  Roni M Shtein
Journal:  Expert Rev Ophthalmol       Date:  2011-10

10.  Relationships among Tear Film Stability, Osmolarity, and Dryness Symptoms.

Authors:  Thao N Yeh; Andrew D Graham; Meng C Lin
Journal:  Optom Vis Sci       Date:  2015-09       Impact factor: 1.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.